Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 527,432 |
|
|||||
| News | - | ||||||
| Day High | 12.60 | Low High |
|||||
| Day Low | 12.21 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Liquidia Corporation | LQDA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.16 | 1.29% | 12.53 | 23:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.37 | 12.21 | 12.60 | 12.53 | 12.37 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,821 | 527,432 | US$ 12.47 | US$ 6,575,259 | - | 5.71 - 16.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:28:42 | 8 | US$ 12.53 | USD |
Liquidia (LQDA) Options Flow Summary
Liquidia Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 951.87M | 76.03M | - | 17.49M | -78.5M | -1.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Liquidia News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LQDA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.68 | 13.97 | 11.80 | 12.85 | 1,124,831 | -1.15 | -8.41% |
| 1 Month | 15.49 | 15.90 | 11.80 | 14.05 | 849,086 | -2.96 | -19.11% |
| 3 Months | 13.76 | 16.99 | 11.80 | 14.51 | 856,335 | -1.23 | -8.94% |
| 6 Months | 6.27 | 16.99 | 6.06 | 12.06 | 991,610 | 6.26 | 99.84% |
| 1 Year | 6.68 | 16.99 | 5.71 | 10.44 | 765,038 | 5.85 | 87.57% |
| 3 Years | 2.87 | 16.99 | 2.25 | 7.04 | 758,896 | 9.66 | 336.59% |
| 5 Years | 9.26 | 16.99 | 2.25 | 6.16 | 644,435 | 3.27 | 35.31% |
Liquidia Description
| Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. |
